Fortress Biotech, Inc. Stock Analysis & AI Score
Fortress Biotech, Inc. (FBIO) has an ST Score of 52.3 (B-), driven by its Profitability (A+) and held back by its Momentum (D-). Analysts rate it Buy with a $5.00 price target (+119.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Fortress Biotech, Inc. (FBIO) has an ST Score of 52.3 (B-), driven by its Profitability (A+) and held back by its Momentum (D-). Analysts rate it Buy with a $5.00 price target (+119.3% upside).
- Strongest
- ProfitabilityA+
- Weakest
- MomentumD-
All factor grades
- ProfitabilityA+
- ForecastA
- GrowthB
- ValuationC-
- Financial StrengthD+
- MomentumD-
- Piotroski6/9
Contact
FBIO stock: frequently asked questions
What is FBIO's ST Score?
Fortress Biotech, Inc. (FBIO) has an ST Score of 52.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is FBIO a buy, hold, or sell?
Analysts rate FBIO a Buy, with a price target of $5.00 (+119.3% vs the current price). Our ST Score grades it B- (52.3/100). The ST Score is a data-driven signal, not a recommendation.
What are FBIO's factor grades?
Valuation C-, Profitability A+, Financial Strength D+, Momentum D-, Growth B, Forecast A.
What is FBIO's valuation grade?
Fortress Biotech, Inc. (FBIO) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is FBIO's growth grade?
Fortress Biotech, Inc. (FBIO) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is FBIO's profitability grade?
Fortress Biotech, Inc. (FBIO) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is FBIO's financial strength grade?
Fortress Biotech, Inc. (FBIO) earns a financial strength grade of D+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for FBIO?
The average analyst price target for Fortress Biotech, Inc. (FBIO) is $5.00 from 6 analysts, which is +119.3% versus the recent price of $2.28.
What is FBIO's Piotroski score?
Fortress Biotech, Inc. (FBIO) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.